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Postoperative nausea and vomiting (PONV) remains a frequent anaesthetic-related complication in both adults and children, with nausea occurring more often than vomiting. 1e4 In adults, the visual analogue scale (VAS) is an accurate tool to quantify the severity of subjective symptoms, such as nausea and pain, but this instrument may not be reliable in the paediatric patient population, particularly in young children. 1,5e9 Therefore, vomiting is used as an objective outcome measure and indication for rescue anti-emetics in children. 4, 10 Pictorial scales are often easier to use than the VAS for measuring pain in children. 11 Recently, a pictorial scale for measuring nausea, the Baxter Retching Faces (BARF) scale, was developed and validated using methods derived from pain measurement studies (Fig. 1) . 12 However, the BARF validation study was limited to English-speaking children. 12 Instruments for self-reported outcomes should be validated in different languages, because cultural differences may be responsible for ethnic variations in self-reported postoperative complications. 13, 14 For example, there is a disparity in postoperative analgesia provided to the Hispanic patient population. 15 This study was designed to validate the BARF scale in measuring the severity of nausea in Spanish-speaking children and to examine the clinical usefulness of this scale. The secondary aim of the study was to determine the important characteristics of the BARF scale that were not examined in the initial validation study, 12 but must be established before the scale is used widely in clinical practice. These included: (i) the score on the BARF scale associated with a patient's perceived need for treatment, (ii) the minimum change in the scores of clinical relevance, and (iii) the testeretest reliability of the BARF scale.
Methods
This study was approved by the Institutional Review Board of the Baylor College of Medicine, registered at www. clinicaltrials.gov (NCT 02007109 on December 5, 2013) and performed with written informed consent of the parent/legal guardian and age-appropriate assent of the subject. Healthy Spanish-speaking children scheduled for elective ambulatory surgery were recruited if they were between 7 and 18 yr of age, and free from major concurrent disorders, including nausea or vomiting in the previous 24 h. We excluded children with developmental delay; blindness; and impaired cognitive, visual, hearing, or communicative skills; or undergoing procedures that may have resulted in diminished hearing or vision in the postoperative period. A certified Spanishspeaking investigator used a seriation task and clinical vignettes to screen for the child's ability to self-report symptom severity. In the seriation task, the child was presented with six cut-out shapes of different sizes and asked to first choose the largest size, then the smallest, and then the largest remaining size until no more shapes were left. 16 In the clinical vignette, the child was asked to rate the comparative severity of pain in three situations: (i) when the doctor placed a stethoscope on the chest, (ii) when the child scraped a knee on the playground, and (iii) when receiving an injection.
12
Children who passed the screening tests were asked to provide baseline assessments of pain and nausea on both the VAS and a pictorial scale [Faces Pain Scale -Revised (FPS-R) for pain and BARF for nausea]. 12, 17 The script for the scales was standardised in keeping with previous studies, and presented by the certified Spanish-speaking researcher (Supplementary material). The order of presentation of scales for assessment was randomised to reduce the potential for an order effect. The order assignments were based on a random number generator and kept in sealed envelopes. The choice of anaesthetic techniques; monitoring and perioperative management; and drugs, including preoperative anxiolytics, anti-emetic for prophylaxis and rescue therapy, and supplemental and rescue analgesics, was determined by the consultant anaesthetist according to the clinical needs and was not changed for the purposes of the study. After the children were awake in the PACU, they rated their pain and nausea using the same scales in the same order as in the preoperative area. This was repeated immediately before and 30e60 min after receiving rescue analgesic or anti-emetic drug treatment. In addition, patients rated changes in nausea on a 5-point Likert scale as much worse than before (1), a little 
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worse than before (2), the same as before (3), a little better than before (4), and much better than before (5). They were also asked if they felt a need for treatment of their nausea (response recorded as 'yes' or 'no').
The patients were discharged from the PACU when they achieved standardised institutional discharge criteria. The parents were given a diary to record the maximum nausea on the VAS and BARF scales, and to mail it back in a stamped envelope. The parents were contacted by phone 24 h after surgery to determine if the child had any nausea and vomiting, and what medications were given after discharge.
Statistical analysis
Children with scores higher than the baseline preoperative BARF score were considered to have postoperative nausea. Data are presented as mean [standard deviation (SD)] and counts (percentages), and analysed using SAS version 9.4 (SAS Institute, Cary, NC, USA). Unpaired data not normally distributed were compared using a ManneWhitney test. For tests with paired data, comparisons were limited to the first available paired scores to avoid using scores from the same patient twice. If the data did not have a Gaussian distribution, we used a Wilcoxon signed-rank test for testing a priori hypotheses, including the comparison of pretreatment and post-treatment BARF and VAS scores for nausea. P-values of <0.05 were considered statistically significant.
Validation
The following a priori hypotheses were developed, based on the assumption that anti-emetics would also reduce nausea:
(i) Hypothesis 1 (construct validity): Children who received rescue anti-emetics in the postoperative period would have higher postoperative nausea scores on the BARF scale and VAS than those who did not receive rescue antiemetics. In addition, these children would have higher nausea scores at the time they received the rescue drug compared with baseline pre-induction scores. (ii) Hypothesis 2 (convergent validity): There would be a good correlation between the BARF and VAS scores for nausea (Spearman coefficient >0.75).
(iii) Hypothesis 3 (discriminant validity):
The correlation between the BARF and VAS scores for nausea would be significantly different from the correlation between the BARF and VAS scores for pain. (iv) Hypothesis 4 (sensitivity to change): Nausea scores would be lower in children after the administration of an antiemetic.
Sample size
For Hypotheses 1, 2, and 4, power calculations were based on the assumption that a change in the VAS by 2.2 cm and by one face on the faces scale were clinically important. 18, 19 Assuming that the SD of postoperative nausea was similar to published data (2.4 cm) in children undergoing day surgery, 12 20 We planned to obtain data on 19 subjects with emesis to allow for missing data because of emergence delirium, delayed recovery, lack of cooperation from pain-related behaviours, or for other reasons. Assuming the incidence of emesis in the PACU was 10% in subjects receiving current standard perioperative care, 3 we would need to enrol 190 subjects to obtain 19 with PACU emesis. For Hypotheses 2 and 3, a sample size of 127 would be required for an estimated maximum Spearman's r correlation estimate of 0.8, a half-width of the confidence interval of 0.1 at an a of 0.01. 21 
Secondary endpoints
The score on the BARF scale associated with a patient's perceived need for treatment was examined by a receiveroperating-characteristic (ROC) curve of the true-positive vs false-positive rates, and determining the sensitivity and specificity at various cut-off points. The minimum clinically relevant change in BARF and VAS scores for nausea was determined by calculating the change in scores for patients who rated their nausea to be 'a little better than before' or 'a little worse than before'. The first and subsequent scores in subjects who rated their symptoms as 'no change from before' were examined using an intra-class coefficient >0.7 as the criterion for testeretest reliability.
Results

PACU data
A total of 184 subjects (110 males and 74 females) with a mean (SD) age of 10.9 (3.0) yr were enrolled in the study (Fig. 2) . The nausea scores on the BARF scale were higher in the PACU compared with baseline preoperative values in 63 children [34.2%; 95% confidence interval (CI): 27.4e41.6%), with six having severe nausea defined as a score 6 (3.3%; 95% CI: 1.2e7.0%). Vomiting occurred in eight subjects (4.3%; 95% CI: 1.9e8.4%), including three with severe nausea, but none had severe emesis in the PACU (3 episodes). A total of 63 had some postoperative nausea or vomiting, with seven having both PONV (Fig. 3) . Rescue anti-emetics were administered to 13 children (7.1%; 95% CI: 3.8e11.8%), including three of six with severe nausea.
Post-discharge data
Only 82 subjects returned diaries despite repeated attempts to contact the subjects, and the post-discharge data analysis was limited to this group (Fig. 4) . Post-discharge nausea was recorded in 17 (20.7%; 95% CI: 12.6e31.1%), with nine having severe post-discharge nausea (11%; 95% CI: 5.1e19.8%). Three of the seventeen with post-discharge nausea had nausea in the PACU, whilst the other 14 developed it only after discharge. Ten children had vomiting after discharge (12.2%; 95% CI: 6.0e21.3%), with two having severe emesis (2.4%; 95% CI: 0.3e8.5%). No child with post-discharge emesis had emesis whilst in hospital. Only one child received anti-emetics after discharge. Twenty-seven children (32.9%; 95% CI: 22.9e44.2%) had some post-discharge nausea or vomiting (PDNV), with five having both symptoms (6.1%; 95% CI: 2e32.7%).
Validation hypotheses
The results for the validation hypotheses are presented below. 
Secondary endpoints
The ROC curve for BARF scores and a patient-perceived need for anti-emetic therapy had an area under the curve of 0.899 (95% CI: 0.82e0.98), indicating an excellent agreement. A cutoff point of 4 had a sensitivity of 57.1% and specificity of 90.2% for the perceived need for anti-emetic therapy.
The minimum clinically relevant change in paired observations of the BARF score in 88 children who rated their nausea as 'a little better than before' or 'a little worse than before' was 1.2 (SD: 1.7; 95% CI: 1.5e2.0).
In 21 subjects who rated their nausea as 'same as before', the Cronbach's a for BARF scores was 0.86. The intra-class coefficient was 0.88 (95% CI: 0.76e0.94). This indicates excellent testeretest reliability.
Discussion
This study has shown that the pictorial BARF scale has construct, convergent, and discriminant validity as a selfreported measure of the severity of nausea in Spanishspeaking children. Construct validity was shown by significantly higher BARF scores in children who received anti-emetics. Convergent validity was shown by the good correlation between the BARF scores and VAS for nausea, the current 'gold standard' for quantifying this subjective symptom in adults. 5 These findings are similar to a previous report in surgical and non-surgical English-speaking children, where there was a greater correlation between the BARF and VAS nausea scores [0.93 (95% CI: 0.91e0.95) vs 0.72 (0.64e0.78) in our study]. 12 Discriminant validity was shown by the significantly decreased correlation between the BARF and pain scores compared with the correlation between the BARF and VAS nausea scores. The BARF scale scores were also sensitive to change with higher scores in the PACU compared with baseline scores and a decrease after rescue anti-emetic therapy.
Our study provides evidence that the BARF scale is a valid instrument in a patient population with a different ethnicity, cultural, and language background compared with the original validation study. 12 There are a number of tools used for selfreported outcomes that have been validated when presented to patients in English. It is not enough to translate the original English instructions into another language, and assume that the validity and reliability demonstrated in a specific group will be equal for different populations, especially when language and cultural differences are considerable. 23 It is necessary to examine the psychometric properties separately for the translated instrument as was done in our study. Our study has also provided evidence that the scale has testeretest reliability. This property of the BARF scale was not examined in the initial validation. A number of findings in this study have clinical implications. We have shown that the perceived need for rescue anti-emetics was higher in patients with a BARF score 4. This is similar to adult studies using the VAS for nausea where the threshold for treatment was 4.
5 However, many of our patients with moderate-to-severe nausea did not receive anti-emetics, as they did not vomit. This is in keeping with the recently updated Guidelines from the Association of Paediatric Anaesthetists of Great Britain and Ireland, which focused on postoperative vomiting and not on nausea. 10 In contrast, large-scale studies in adults show they are more likely to receive anti-emetics in the PACU for clinically significant nausea than for emesis. 1, 2, 24 We may be undertreating children with nausea in the PACU, as we do not routinely measure the severity of this condition in the paediatric patient population. Failure to measure nausea severity may also occur in non-surgical paediatric patient populations, such as those receiving chemotherapy and children presenting with gastrointestinal complaints for urgent care. We have also shown that the minimum clinically relevant change in BARF scores is 1.2. The BARF scale consists of six faces with an assumed difference in score of 2 between each face. This suggests that a one face change can be used as the smallest improvement in nausea that we can detect with the BARF score after rescue anti-nausea therapy in an individual patient. Studies comparing the effect of a drug on the severity of nausea in a group of subjects should be powered to detect at least the minimum clinically relevant change in nausea scores of 1.2. The minimum clinically significant difference in the VAS scores for nausea in adults in the emergency department was 2.2 cm. 19 Our study has confirmed that children may develop nausea or vomiting after discharge (PDNV) from the hospital. The incidence of PDNV in our study (32.9%) was higher than the 14.1% rate reported in another paediatric study. 3 This increased incidence may be explained by differences in patient selection and the criteria used for PDNV. Efune and colleagues 3 studied a cohort of patients and did not measure the severity of nausea, but recorded the parent's response to the question about nausea. It is possible that recall would have been higher in those with more severe nausea, and so their study may have identified only the more severe cases. We used a change in nausea scores over the baseline or the occurrence of emesis to classify a child as having PDNV. Both studies can be criticised for the large dropout rate after discharge. However, both studies noted that the occurrence of nausea or vomiting symptoms in the PACU was not predictive of PDNV.
Other limitations of our study include the use of the VAS for nausea as a comparator for the BARF scores. The VAS for nausea has not been well established for paediatric nausea studies unlike the VAS for pain or the VAS for nausea in adults. However, we considered it reasonable to use the VAS for nausea in view of the previous study in English-speaking subjects. 12 The study may also be criticised for being limited to older subjects undergoing ambulatory surgery and for not determining the patient preference for one scale over the other. However, the validity of the scale needed to be established in children who spoke languages other than English before performing studies on the generalisability and clinical value of the BARF scale. A validation study requires older subjects with the conceptual ability to use both the VAS and the pictorial scale. Additional studies should be designed to determine if the BARF scale can be reliably used in younger children and in children who failed the screening tests, and ascertain if therapy based on nausea scores would improve patient-and parent-reported quality of recovery after anaesthesia as measured by scales validated in children. 25 In conclusion, the pictorial BARF scale has construct, convergent, discriminant, and testeretest validity as a selfreported measure of the severity of nausea in Spanishspeaking children. It is sensitive to change with a minimum clinically relevant difference of 1.2 and an increased patient perceived need for rescue therapy when the score was 4.
